Pharmacology and use of muscle relaxants in infants and children.
Succinylcholine is a short-acting depolarizing neuromuscular blocker used to facilitate intubation; pancuronium is a longer-acting, nondepolarizing agent commonly employed to control ventilation in pediatric patients. The neuromuscular block produced by both drugs may be modified by patient age, acid-base and electrolyte status, body temperature, and drugs such as aminoglycoside antibiotics; adjustment in dose or in technique of administration may be required. Cardiovascular side-effects, primarily arrhythmias, are occasionally associated with the use of either agent. In contrast to that of succinylcholine, the paralysis from pancuronium is pharmacologically reversible with the combination of atropine and neostigmine.
D000200:Action Potentials / Q000187:drug effects; D002648:Child; D002802:Cholinesterases / Q000097:blood; D005703:Gallamine Triethiodide / Q000494:pharmacology; D006801:Humans; D007223:Infant; D007442:Intubation, Intratracheal; D009388:Neostigmine / Q000494:pharmacology; D009466:Neuromuscular Blocking Agents / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology*; D009469:Neuromuscular Junction / Q000187:drug effects; D010197:Pancuronium / Q000494:pharmacology; D013390:Succinylcholine / Q000008:administration & dosage / Q000494:pharmacology*; D014403:Tubocurarine / Q000494:pharmacology
D009466:Neuromuscular Blocking Agents; D009388:Neostigmine; D002802:Cholinesterases; D013390:Succinylcholine; D010197:Pancuronium; D005703:Gallamine Triethiodide; D014403:Tubocurarine